Hepatitis C Treatment in People Who Inject Drugs

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

“…We report the program costs of a novel intervention providing co-located HCV treatment and care coordination at an SSP in New York City. Multiple studies describe successful real-world outcomes of providing co-located care for HCV at SSPs, including several in New York City ( Eckhardt, 2016 ; Miller et al, 2019 ; Muncan et al, 2021 ; Schulkind et al, 2019 ; Winetsky et al, 2020 ). While data collected from PWID show a high level of acceptability for this intervention, investments in staff and equipment are necessary to build and maintain such a program.…”